Clinical Trials in Pisa, Pisa
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Non-small Cell Lung CancerNSCLCNSCLC (Advanced Non-small Cell Lung Cancer)+2 more
Revolution Medicines, Inc.420 enrolled129 locationsNCT06881784
Recruiting
Phase 2
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
LeiomyosarcomaSolid Organ Transplant ComplicationsLymphoproliferative Disorders+8 more
Pierre Fabre Medicament190 enrolled40 locationsNCT04554914
Recruiting
Predictors of Emergency Department Use in Frail Patients
ElderlyFrailtyAlzheimer s Disease+3 more
University of Pisa110 enrolled1 locationNCT07259499
Recruiting
ALFAOMEGA Master Observational Trial
Colorectal, Cancer
IFOM ETS - The AIRC Institute of Molecular Oncology3,000 enrolled19 locationsNCT04120935
Recruiting
A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)
Colorectal, Cancer
IFOM ETS - The AIRC Institute of Molecular Oncology500 enrolled13 locationsNCT05101382
Recruiting
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
Squamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the Anus
National Cancer Institute, Naples170 enrolled4 locationsNCT06236464